ArticleProceedings of the National Academy of Sciences of the United States of America2021

Targeting loss of heterozygosity for cancer-specific immunotherapy.

Michael S Hwang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.